Bronson Crouch

Bronson Crouch

Director Ejecutivo en INSTIL BIO, INC. .

Fortuna: 22 M $ al 30/04/2024

51 años
Health Technology
Finance

Origen de la red de primer grado Bronson Crouch.

EntidadTipo de entidadIndustria
Public Company Biotechnology 15
Public Company Biotechnology 14
Subsidiary Pharmaceuticals: Major 14
Subsidiary Pharmaceuticals: Major 6

Gráfico Empresas conectadas de segundo grado

Relaciones con varias empresas

Empresas conectadas a Bronson Crouch a través de su red personal

EmpresaSectorPersonas relacionadasPuesto principal
AMGEN INC. Pharmaceuticals: Major

David Hallal

David Chang

Zachary Roberts

Sales & Marketing

Private Equity Investor

Chief Tech/Sci/R&D Officer

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Jill DeSimone

Viera Muzithras

Kevin Zikaras

Corporate Officer/Principal

General Counsel

Corporate Officer/Principal

FIRST DATA CORPORATION Regional Banks

Matthew Call

Corporate Officer/Principal

Biotechnology

Sumita Ray

Timothy Moore

General Counsel

Corporate Officer/Principal

GE AEROSPACE Industrial Machinery

Matthew Call

Corporate Officer/Principal

MERCK & CO., INC. Pharmaceuticals: Major

Jill DeSimone

Robert Iannone

Tony Ho

Corporate Officer/Principal

Director/Board Member

Corporate Officer/Principal

PFIZER, INC. Pharmaceuticals: Major

Neil Gibson

Gregg McConnell

Corporate Officer/Principal

Corporate Officer/Principal

ASTRAZENECA PLC Pharmaceuticals: Major

Robert Iannone

Corporate Officer/Principal

Movies/Entertainment

Matthew Call

Corporate Officer/Principal

BIOGEN INC. Pharmaceuticals: Major

David Hallal

Angela Justice

Sales & Marketing

Corporate Officer/Principal

SAREPTA THERAPEUTICS, INC. Pharmaceuticals: Major

Matthew Gall

Adi Osovsky

Corporate Officer/Principal

Corporate Officer/Principal

Investment Managers

David Chang

Private Equity Investor

REATA PHARMACEUTICALS, INC. Pharmaceuticals: Major

Jack Nielsen

Richard McGaughy

Director/Board Member

Director/Board Member

Stanford University College/University

David Chang

Naseem Zojwalla

Mark Dudley

Doctorate Degree

Undergraduate Degree

Doctorate Degree

University of Pennsylvania College/University

Gwendolyn Binder-Scholl

Tony Ho

Corporate Officer/Principal

Corporate Officer/Principal

University of Cambridge College/University

George Matcham

Robert Hawkins

Graduate Degree

Doctorate Degree

Massachusetts Institute of Technology College/University

David Chang

Undergraduate Degree

College/University

Helen Kim

Timothy Moore

Undergraduate Degree

Graduate Degree

Rutgers State University of New Jersey College/University

Nimish Shah

Viera Muzithras

Undergraduate Degree

Undergraduate Degree

The University of Texas at Austin College/University

Richard McGaughy

Brett A. Ringle

Undergraduate Degree

Undergraduate Degree

The University of Chicago College/University

Helen Kim

Angela Justice

Masters Business Admin

Doctorate Degree

The Johns Hopkins University College/University

Gwendolyn Binder-Scholl

Tony Ho

Doctorate Degree

Corporate Officer/Principal

College/University

Sandeep Laumas

Gregg McConnell

Undergraduate Degree

Undergraduate Degree

College/University

Jill DeSimone

Kevin Zikaras

Undergraduate Degree

Graduate Degree

The Pennsylvania State University College/University

Vijay Chiruvolu

Richard Roomberg

Masters Business Admin

Undergraduate Degree

Pharmaceuticals: Major

Ann Rhoads

David Hallal

Matthew Call

Tim van Hauwermeiren

Michel Detheux

Director/Board Member

Chairman

Chief Operating Officer

Director/Board Member

Founder

KITE PHARMA INC Biotechnology

Helen Kim

Timothy Moore

David Chang

Zachary Roberts

Vijay Chiruvolu

Private Equity Investor

Chief Tech/Sci/R&D Officer

Private Equity Investor

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Harvard Business School College/University

Ann Rhoads

Richard McGaughy

David Lee

Masters Business Admin

Masters Business Admin

Masters Business Admin

ALLOGENE THERAPEUTICS, INC. Biotechnology

Timothy Moore

David Chang

Zachary Roberts

Chief Tech/Sci/R&D Officer

Founder

Chief Tech/Sci/R&D Officer

ADAPTIMMUNE THERAPEUTICS PLC Biotechnology

William Bertrand

Gwendolyn Binder-Scholl

Chief Operating Officer

Chief Tech/Sci/R&D Officer

Miscellaneous Commercial Services

Helen Kim

David Chang

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Helen Kim

Timothy Moore

Director/Board Member

President

Biotechnology

Helen Kim

David Chang

Director/Board Member

Chairman

The University of Chicago Booth School of Business College/University

Helen Kim

Matthew Gall

Graduate Degree

Masters Business Admin

Investment Managers

Helen Kim

David Chang

Private Equity Investor

Consultant / Advisor

APOLLO ENDOSURGERY, INC. Medical Specialties

Jack Nielsen

Richard McGaughy

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Nimish Shah

Viera Muzithras

Corporate Officer/Principal

Public Communications Contact

University of Illinois At Urbana–Champaign College/University

John Moore

Peter Olagunju

Graduate Degree

Undergraduate Degree

BIVICTRIX THERAPEUTICS PLC Pharmaceuticals: Major

Robert Hawkins

Alex Hughes

Director/Board Member

Director of Finance/CFO

Biotechnology

David Chang

Corporate Officer/Principal

Investment Managers

David Chang

Director/Board Member

Purdue University College/University

Matthew Call

Masters Business Admin

David Geffen School of Medicine College/University

David Chang

Corporate Officer/Principal

ENDOCYTE, INC. Pharmaceuticals: Major

Matthew Call

Chief Operating Officer

Pharmaceuticals: Other

David Chang

Director/Board Member

Pharmaceuticals: Major

David Chang

Director/Board Member

APOGEE THERAPEUTICS, INC. Biotechnology

Nimish Shah

Founder

Estadísticas

Internacional

Estados Unidos 42
Reino Unido 5
Francia 2
Bélgica 2
Canadá 2

Sectorial

Health Technology 25
Consumer Services 18
Finance 6
Producer Manufacturing 2
Commercial Services 2

Operativa

Director/Board Member 168
Corporate Officer/Principal 102
Independent Dir/Board Member 57
Undergraduate Degree 36
Chief Tech/Sci/R&D Officer 30
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA